Department of Orthopedic Surgery, Kosin University Gospel Hospital, Busan, Korea.
J Surg Oncol. 2011 Aug 1;104(2):187-91. doi: 10.1002/jso.21902. Epub 2011 Mar 11.
An extracorporeal irradiated (ECI) autograft was first reported in Israel in 1968 for the treatment of primary malignant bone tumor. However, subsequent reports covered mostly short-term follow up results, and the reported results of reconstruction vary from study to study. We analyze the long-term follow up results of reconstruction using an extracorporeal irradiated (ECI) autograft in osteosarcoma around the knee.
We retrospectively reviewed 23 osteosarcoma patients who underwent reconstruction with ECI between December 1995 and April 2005. The 15 males and 8 females had a mean age of 21 years (range: 7-74) and a mean follow-up of 127 months(range: 57-170). Tumors were located in the distal femur in 14 cases, and the proximal tibia in 9 cases. Pathological types were conventional in 22 cases, and parosteal in 1 case. Resection methods were osteoarticular in 18 cases and total joint in 5 cases. Eighteen cases were reconstructed with the ECI autograft and five with ECI autograft-prosthesis composite (APC). The Musculoskeletal Tumor Society (MSTS) score was used for functional evaluation. The overall survival rate, local recurrence, complications were analyzed.
The overall survival rate was 82.6%, and the disease-free survival rate was 69.5%. We found 20 complications, including 6 nonunions, 5 deep infections, 4 joint instabilities, 2 fractures, 1 limb-length discrepancy (LLD), 1 epiphyseal collapse, and 1 vessel occlusion. The average MSTS functional score was 62.6%.
Reconstruction with an extracorporeal irradiated is not recommended for osteosarcoma around the knee.
1968 年,以色列首次报道了一种体外辐照(ECI)自体移植物,用于治疗原发性恶性骨肿瘤。然而,随后的报道大多涵盖了短期随访结果,并且研究之间的重建报告结果也有所不同。我们分析了体外辐照(ECI)自体移植物在膝关节周围骨肉瘤中的长期随访结果。
我们回顾性分析了 1995 年 12 月至 2005 年 4 月期间接受 ECI 重建的 23 例骨肉瘤患者。15 名男性和 8 名女性的平均年龄为 21 岁(范围:7-74 岁),平均随访时间为 127 个月(范围:57-170 个月)。肿瘤位于 14 例股骨远端,9 例胫骨近端。病理类型为常规型 22 例,骨旁型 1 例。18 例采用关节内切除术,5 例采用全关节切除术。18 例采用 ECI 自体移植物重建,5 例采用 ECI 自体移植物-假体复合(APC)重建。采用肌肉骨骼肿瘤学会(MSTS)评分进行功能评估。分析总生存率、局部复发率、并发症。
总体生存率为 82.6%,无疾病生存率为 69.5%。我们发现 20 例并发症,包括 6 例骨不连、5 例深部感染、4 例关节不稳定、2 例骨折、1 例肢体长度差异(LLD)、1 例骨骺塌陷和 1 例血管闭塞。平均 MSTS 功能评分 62.6%。
不建议在膝关节周围骨肉瘤中使用体外辐照重建。